Iterum Therapeutics plc ITRMF
At closeNov 11, 2026, 4:00 PM EST
- YTD
- -100.00%
- 1 year
- -100.00%
ITRMF free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-26,772,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | -26,772,000 | 12,571,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -39,343,000 | -20,808,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -18,535,000 | -2,632,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -15,903,000 | 38,636,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -54,539,000 | 27,407,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -81,946,000 | -4,604,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -77,342,000 | -45,926,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -31,416,000 | -20,118,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -11,298,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-04-10T14:45:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.